Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading.

Not Applicable

• Conditions: Type 2 Diabetes mellitus

• Registration Number: JPRN-UMIN000015778
• Lead Sponsor: Kanazawa Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-11-28
• Study Completion: 2015-06-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient who had SGLT2 inhibitor with past 2 months. 2) Patient whose concomitant drug had changed with past 2 months. 3) Patient who is diagnosed as contraindication of tofogliflozin. (1) Patient with a history of hypersensitivity to any of the components of the product (2) Patient with a severe ketotic diabetic coma or precoma. (3) Patient with severe infectious disease, before and after operation, and a serious injury. 4) Patient receiving other diabetes drugs. 5) Patient with severe renal disorder (estimated GFR< 30mL/min/1.73m2). 6) Patient with a history of cerebral infarction. 7) Patient receiving diuretic drugs. 8) Patient whom the principle investigator or other investigator consider unsuitable.

Study & Design

• Study Type: Interventional
• Study Design: Not specified